Authors:
Suchowersky, O
Bailey, P
Pourcher, E
Bulger, L
Facciponte, G
Citation: O. Suchowersky et al., Comparison of two dosages of tolcapone added to levodopa in nonfluctuatingpatients with PD, CLIN NEUROP, 24(4), 2001, pp. 214-220
Authors:
Brown, CA
Lanning, RW
McKinney, KQ
Salvino, AR
Cherniske, E
Crowe, CA
Darras, BT
Gominak, S
Greenberg, CR
Grosmann, C
Heydemann, P
Mendell, JR
Pober, BR
Sasaki, T
Shapiro, F
Simpson, DA
Suchowersky, O
Spence, JE
Citation: Ca. Brown et al., Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifussmuscular dystrophy, AM J MED G, 102(4), 2001, pp. 359-367
Authors:
DeStefano, AL
Golbe, LI
Mark, MH
Lazzarini, AM
Maher, NE
Saint-Hilaire, M
Feldman, RG
Guttman, M
Watts, RL
Suchowersky, O
Lafontaine, AL
Labelle, N
Lew, MF
Waters, CH
Growdon, JH
Singer, C
Currie, LJ
Wooten, GF
Vieregge, P
Pramstaller, PP
Klein, C
Hubble, JP
Stacy, M
Montgomery, E
MacDonald, ME
Gusella, JF
Myers, RH
Citation: Al. Destefano et al., Genome-wide scan for Parkinson's disease: The GenePD study, NEUROLOGY, 57(6), 2001, pp. 1124-1126
Authors:
Kieburtz, K
Koroshetz, W
McDermott, M
Beal, MF
Greenamyre, JT
Ross, CA
Shoulson, I
Cudkowicz, ME
Sexton, P
Skeuse, C
Rosas, D
Jenkins, B
Rosenblatt, A
Sherr, M
Hersch, S
Cellar, J
Guttman, M
Brown, C
Como, PG
Marshall, F
DeMarcaida, JA
Zimmerman, C
Marder, K
Moskowitz, C
Polanco, C
Beltre, J
Shannon, K
Jaglin, JA
Niederman, F
Ashizawa, T
Hunter, C
Hunter, C
Hauser, R
Walker, A
Gauger, L
Hahn, MA
Delgado, H
Dawson, T
Siemers, E
Seeberger, L
Dingmann, C
Dubinsky, R
Gray, C
Weiner, WJ
Rodriguez-Batemen, D
Albin, RL
Wernette, K
Harrison, M
Rost-Ruffner, E
Paulsen, J
Rodnitzky, RL
Dobson, J
Vining, L
Suchowersky, O
Pantella, C
Saint-Hilaire, MH
Furtado, J
Martin, W
Wieler, M
Walker, F
Hunt, V
Raymond, L
Almqvist, E
Rubin, A
Blair, B
Marek, K
Caplan, K
Baker, D
Brocht, A
Casaceli, C
Orme, C
Rudolph, A
Rumfola, L
Schifitto, G
Shinaman, A
Sulimowicz, K
Watts, A
Eapen, S
Zhang, L
Citation: K. Kieburtz et al., A randomized, placebo-controlled trial of coenzyme Q(10) and remacemide inHuntington's disease, NEUROLOGY, 57(3), 2001, pp. 397-404
Authors:
Shoulson, I
Penney, J
McDermott, M
Kieburtz, K
Schwid, SR
Kayson, E
Chase, T
Fahn, S
Greenamyre, JT
Lang, A
Siderowf, A
Pearson, N
Harrison, M
Rost-Ruffner, E
Colcher, A
Lloyd, M
Matthews, M
Pahwa, R
McGuire, D
Lew, MF
Schuman, S
Marek, K
Broshjeit, S
Factor, S
Brown, D
Feigin, A
Mazurkiewicz, J
Ford, B
Jennings, D
Dillon, S
Comella, C
Blasucci, L
Janko, K
Shulman, L
Wiener, W
Bateman-Rodriguez, D
Carrion, A
Suchowersky, O
Lafontaine, AL
Pantella, C
Siemers, E
Belden, J
Davies, R
Lannon, M
Grimes, D
Gray, P
Martin, W
Kennedy, L
Adler, C
Newman, S
Hammerstad, J
Stone, C
Lewitt, P
Bardram, K
Mistura, K
Miyasaki, J
Johnston, L
Cha, JHJ
Tennis, M
Panisset, M
Hall, J
Tetrud, J
Friedlander, J
Hauser, R
Gauger, L
Rodnitzky, R
Deleo, A
Dobson, J
Seeberger, L
Dingmann, C
Tarsy, D
Ryan, P
Elmer, L
Ruzicka, D
Stacy, M
Brewer, M
Locke, B
Baker, D
Casaceli, C
Day, D
Florack, M
Hodgeman, K
Laroia, N
Nobel, R
Orme, C
Rexo, L
Rothenburgh, K
Sulimowicz, K
Watts, A
Wratni, E
Tariot, P
Cox, C
Leventhal, C
Alderfer, V
Craun, AM
Frey, J
McCree, L
McDermott, J
Cooper, J
Holdich, T
Read, B
Citation: I. Shoulson et al., A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease, NEUROLOGY, 56(4), 2001, pp. 455-462
Authors:
Chong, DJ
Suchowersky, O
Szumlanski, C
Weinshilboum, RM
Brant, R
Campbell, NRC
Citation: Dj. Chong et al., The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease, CLIN NEUROP, 23(3), 2000, pp. 143-148
Authors:
Holloway, R
Shoulson, I
Fahn, S
Kieburtz, K
Lang, A
Marek, K
McDermott, M
Seibyl, J
Weiner, W
Welsh, M
Kamp, C
Day, D
Pahwa, R
Smith, D
McGuire, D
Barclay, L
Sutherland, L
Hildebrand, K
Hubble, J
Weeks, C
LeWitt, P
Mistura, K
Bloomfield, W
Miyasaki, J
Duff, J
Sime, E
Suchowersky, O
Argatoff, P
Andreas, Y
Kurth, M
Brewer, M
Russell, D
Fussell, B
Ford, B
Dillon, S
Hammerstad, J
Stone, C
Riley, D
Rainey, P
Standaert, D
Tennis, M
Wooten, F
Rost-Ruffner, E
Factor, S
Brown, D
Jankovic, J
Beach, J
Kurlan, R
Gardiner, I
Panisset, M
Amyot, D
Hall, J
Rajout, A
Wilson, W
McCullan, L
Brown, K
Clark, R
Rodnitzky, R
Dobson, J
Shults, C
Fontaine, D
Waters, C
Welsh, M
Pfeiffer, R
Rast, S
Bujak, G
Casaceli, C
Freimuth, A
Hodgeman, K
Honsinger, K
Watts, A
Hall, WJ
Leventhal, CM
Reich, S
Tariot, P
Balgoyen, D
Corak, D
Corrigan, M
Driver, M
Fraser, TJ
Lai, PY
Gomez-Mancilla, B
Munting, J
Peters, G
Rowland, C
Sullivan, H
Trasky, R
Wright, G
Berber, E
Morris, J
Mills, D
Hallak, L
Rines, S
Citation: R. Holloway et al., A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study, CLIN NEUROP, 23(1), 2000, pp. 34-44
Authors:
Holloway, R
Shoulson, I
Kieburtz, K
McDermott, M
Tariot, P
Kamp, C
Day, D
Shinaman, A
Fahn, S
Lang, A
Marek, K
Seibyl, J
Weiner, W
Welsh, M
Pahwa, R
Coe, S
Barclay, L
Sutherland, L
Hildebrand, K
Hubble, J
Weeks, C
LeWitt, P
Miyasaki, J
Duff, J
Sime, E
Suchowersky, O
Stacy, M
Kurth, M
Brewer, M
Harrigan, M
Russell, DS
Fussell, B
Ford, B
Dillon, S
Hammerstad, J
Stone, C
Riley, D
Rainey, P
Standaert, D
Tennis, M
Wooten, F
Rost-Ruffner, E
Factor, S
Brown, D
Jankovic, J
Atassi, F
Kurlan, R
Gardiner, I
Panisset, M
Amyot, D
Hall, J
Rajput, A
Shirley, T
Rodnitzky, R
Dobson, J
Shults, C
Fontaine, D
Waters, C
Welsh, M
Schuman, S
Pfeiffer, R
Rast, S
Pfeiffer, B
Brocht, A
Casaceli, C
Daigneault, S
Hodgeman, K
Honsinger, K
O'Connell, C
Watts, A
Citation: R. Holloway et al., Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial, J AM MED A, 284(15), 2000, pp. 1931-1938